Style | Citing Format |
---|---|
MLA | Mahdavi AM, et al.. "Clinical Characteristics and Long-Term Outcome of Takayasu Arteritis in Iran: A Multicentre Study." Turkish Journal of Medical Sciences, vol. 50, no. 4, 2020, pp. 713-723. |
APA | Mahdavi AM, Rashtchizadeh N, Kavandi H, Hajialilo M, Kolahi S, Jafari Nakhjavani MR, Ebrahimi AA, Seyedmardani S, Salesi M, Soroush M, Khabbazi A (2020). Clinical Characteristics and Long-Term Outcome of Takayasu Arteritis in Iran: A Multicentre Study. Turkish Journal of Medical Sciences, 50(4), 713-723. |
Chicago | Mahdavi AM, Rashtchizadeh N, Kavandi H, Hajialilo M, Kolahi S, Jafari Nakhjavani MR, Ebrahimi AA, et al.. "Clinical Characteristics and Long-Term Outcome of Takayasu Arteritis in Iran: A Multicentre Study." Turkish Journal of Medical Sciences 50, no. 4 (2020): 713-723. |
Harvard | Mahdavi AM et al. (2020) 'Clinical Characteristics and Long-Term Outcome of Takayasu Arteritis in Iran: A Multicentre Study', Turkish Journal of Medical Sciences, 50(4), pp. 713-723. |
Vancouver | Mahdavi AM, Rashtchizadeh N, Kavandi H, Hajialilo M, Kolahi S, Jafari Nakhjavani MR, et al.. Clinical Characteristics and Long-Term Outcome of Takayasu Arteritis in Iran: A Multicentre Study. Turkish Journal of Medical Sciences. 2020;50(4):713-723. |
BibTex | @article{ author = {Mahdavi AM and Rashtchizadeh N and Kavandi H and Hajialilo M and Kolahi S and Jafari Nakhjavani MR and Ebrahimi AA and Seyedmardani S and Salesi M and Soroush M and Khabbazi A}, title = {Clinical Characteristics and Long-Term Outcome of Takayasu Arteritis in Iran: A Multicentre Study}, journal = {Turkish Journal of Medical Sciences}, volume = {50}, number = {4}, pages = {713-723}, year = {2020} } |
RIS | TY - JOUR AU - Mahdavi AM AU - Rashtchizadeh N AU - Kavandi H AU - Hajialilo M AU - Kolahi S AU - Jafari Nakhjavani MR AU - Ebrahimi AA AU - Seyedmardani S AU - Salesi M AU - Soroush M AU - Khabbazi A TI - Clinical Characteristics and Long-Term Outcome of Takayasu Arteritis in Iran: A Multicentre Study JO - Turkish Journal of Medical Sciences VL - 50 IS - 4 SP - 713 EP - 723 PY - 2020 ER - |